ABSTRACT
INTRODUCTION
India has one of the highest incidences of oral cancer in the world (1) . Oral cancer ranks number one among men and number three among women in India. Oral cancer constitutes 12% of all cancers in men and 8% of all cancers in women (2) . Oral cancer, the sixth most common cancer worldwide, continues to be the most prevalent cancer related to the consumption of tobacco, alcohol and other carcinogenic products (3). While cancer incidence remain high in south and southeast Asia (traditional high-risk areas), parts of central and eastern Europe are seeing an alarming increase and now constitute the highest incidence region in the globe (4) .
The development of cancer is a multistep process arising from pre-existing potentially malignant lesions. Leukoplakia is the most common pre-cancer, representing 85% of such lesions (5) . Histologically, over 95% of oral cancers are squamous cell carcinoma (6, 7) . It has been suggested that a vast majority of oral squamous cell carcinomas in India arise from pre-existing leukoplakia (4) .
India is a developing country with one of the most diverse populations and diets in the world. Cancer rates in India are lower than those seen in Western countries but are rising with increasing migration of the rural population to the cities, increase in life expectancy and changes in lifestyles. In India, rates for oral and oesophageal cancers are some of the highest in the world. In contrast, rates for colorectal, prostrate and lung cancers are among the lowest (8) . In India, oral cancer is prevalent in areas where tobacco related practices are observed. For development of oral cancer, tobacco is the single greatest risk factor. This is due to higher concentration of carcinogenic exposure and failure to clean the carcinogens from the mucosal surface (8) . Alcohol, viruses, genetic mechanisms, candida and chronic irritation have modifying effects in the aetiology of cancer. Copper, iron, selenium and zinc are essential for numerous enzymes and, therefore, it is reasonable to assume that variations in serum level of these biochemical markers may be associated with the pathogenesis of oral cancer. The importance of these elements in cancer was reported by Schwartz which opened the door for new diagnostic and therapeutic endeavours in many areas of medicine and specifically in the areas of oncology (9) . Epidemiological studies indicate that intervention at an early stage might reduce deaths related to oral carcinoma (9) . Immunological and biochemical alterations in the serum of such patients can help not only in early diagnosis and appropriate treatment but also as indicators for prognosis as the disease progresses. Oral cancer is an extremely deadly disease which comprises approximately 2% of the total malignant tumours in western Europe and North America, but in India it accounts for nearly 50% of the cancers (10) .
Free radicals contain at least one unpaired electron and combine with other molecules to cause cell damage or DNA mutation that leads to carcinogenesis. Antioxidants are produced in the body to counteract this free radical damage and reduce oxidative stress (11) . The presence of antioxidants in the body can help prevent various diseases including cancer.
Effect on general health
Antioxidants such as selenium, vitamin C, vitamin E and carotenoids have been hypothesized as chemopreventive agents for several cancers (11) . The essential trace element, selenium, is of fundamental importance to human health. As a constituent of selenoproteins, selenium has structural and enzymatic roles, in the latter context being best known as an antioxidant. An elevated selenium intake may be associated with reduced cancer risk (11 (12) . In HL-60 cells (promyelocytic leukaemia cells), the zinc up-regulates at A20 mRNA, which, via TRAF pathway, decreases NF-B activation leading to decreased gene expression and generation of tumour necrosis factor (TNF-α, interleukin-1 and IL-8). Zinc supplementation in young adults and elderly subjects decreased oxidative stress markers and decreased generation of inflammatory cytokines. During the past four decades, a spectrum of clinical deficiency of zinc in human subjects has emerged (13) .
Clinical manifestation of zinc deficiency in the developing countries is caused by ingestion of high cereal protein intake, rich in phytate (an organic phosphate compound), which makes zinc unavailable for absorption. Other causes of zinc deficiency include malabsorption syndrome, hyperzincuria as seen in cirrhosis of the liver and sickle cell disease, blood loss due to hookworm infection, and excessive sweating in tropical climates. Manifestations of severe zinc deficiency in humans include bullous pustular dermatitis, alopecia, diarrhoea, emotional disorder, weight loss, intercurrent infections due to cell-mediated immune dysfunctions, hypogonadism in males, neurosensory disorders and problems with healing of ulcers (14) .
The manifestations of a moderate deficiency of zinc include growth retardation, rough skin, poor appetite, mental lethargy, delayed wound healing, cell-mediated immune dysfunctions and abnormal neurosensory changes. In experimental human models in whom only a mild deficiency of zinc in males was induced by dietary means, decreased serum testosterone level, oligospermia, decreased natural killer (NK) cell activity, decreased interleukin-2(IL-2) production, decreased thymulin activity, hyperammonaemia, hypogeusia, decreased dark adaptation, and decreased lean body mass were observed (15, 16) . Zinc affects multiple aspects of the immune system (17) . Zinc is crucial for normal development and function of cells mediating innate immunity, neutrophils and NK cells. Macrophages are also affected by zinc deficiency. Phagocytosis, intracellular killing and cytokine production are affected by zinc deficiency. Zinc deficiency adversely affects the growth and function of T and B cells. The role of zinc in modulating oxidative stress has recently been recognized (18) (19) (20) . The dismutation of oxygen to hydrogen peroxide is catalysed by the enzyme superoxide dismutase (SOD), which contains both copper and zinc. Zinc is known to induce the production of metallothionein which is very rich in cysteine and is an excellent scavenger of ˙OH (21) . Zinc has been shown to inhibit NF-B activation, thus enhancing anticancer therapy (22) .
A significant decrease in serum selenium and zinc levels as well as an increase in serum copper level has been shown in cancer patients (23) . Deficiency manifestation of selenium includes elevated blood mean corpuscular volume (MCV), macrocytosis, unusual hair texture with hypopigmentation (pseudo-albinism), elevated transaminase and creatine kinase activities and profound muscle weakness (24−26) .
The possible role of selenium in cancer prevention has been the subject of great interest, largely because it is a key component of the antioxidant enzyme glutathione peroxidase, although it also has many other potentially anticarcinogenic properties, including effects on DNA repair, apoptosis and effects on the immune system (24) . Much experimental evidence indicates that high doses of selenium supplementation can inhibit carcinogenesis in many tissue types (25) . The realization that several diseases in man are associated with elevated serum copper levels clearly indicates the involvement and likely importance of copper in human health. Copper deficiency may be seen is diseases like Addison's disease, aplastic anaemia, Banti's syndrome, certain carcinomas, central nervous system disorders, collagen diseases, diabetes, Hodgkin's disease, iron deficiency anaemia, hyperthyroidism, leukaemia, malaria, pernicious anaemia, sickle cell anaemia, schizophrenia and thalassaemia.
Total blood copper levels in healthy humans normally range from 1.1-1.5 µg/mL. The recommended daily allowance of copper is 2-3 mg/day, although these values can fluctuate with age, exercise and health condition (26) . Availability of copper in various food sources are as follows: Cereals: 22-30% Meat and fish: 20-30% Fruits and preserves: 11-16% Root vegetables: 14-17% Other vegetables: 10-13% Beverages: 9-14% Milk: 2-3%
Copper enzymes are widely distributed within the body. They perform several diverse functions including transport of oxygen and electrons, catalysis in oxidation reduction reactions and the protection of the cell against damaging oxygen radicals.
The dismutation of superoxide anions by the copper-zinc enzyme superoxide dismutase renders the potentially damaging superoxide anions less harmful by converting them to less reactive H 2 O 2 . The superoxide anion radical can also result in the formation of the dangerous hydroxyl radical. The targets for these radicals are various cellular components and membranes (27) .
Full-blown copper deficiency is rare, as copper is naturally present in many foods. However, many people eat less than the recommended amounts of it. Also, less than 50% of the copper in the diet is absorbed by the body, which leads to sub-optimal levels. Certain conditions give rise to copper deficiency symptoms. Infants fed on cow's milk, low birthweight infants, and children on low protein diets have been found to be short of copper (28) . In the elderly and in people with malabsorption disorders (chronic diarrhoea, Crohn's disease, coeliac disease), nutrients are poorly absorbed which increases the risk of copper deficiency (29) . Zinc, iron and copper compete for amino acid carriers that transport them across intestinal walls into the bloodstream. Hence, high doses of any one of these minerals can cause a deficiency in the others. Copper needs sufficient levels of stomach acid for absorption. Regular use of antacids may therefore increase the risk of deficiency (30) . Calcium and phosphorus can increase the excretion of copper. Prolonged use of oral contraceptives may also upset copper balance in the body. As copper is involved in many biochemical functions in the body, low levels of it can result in a wide range of disorders (31) .
Among the earliest symptoms of copper deficiency are osteoporosis, osteopenia, retarded growth or abnormalities in bone development in low birthweight infants and young children. As copper is needed for the mobilization of iron, deficiency of it is one cause of sideroblastic anaemia, hair loss, impaired immune system that leads to susceptibility to infections, impaired nervous system that may lead to decreased taste sensitivity and lack of physical coordination, inelastic blood vessels that rupture easily, elevated low-density lipoprotein and lower levels, deterioration of heart muscles and irregular heartbeat, breathing difficulties, fatigue and weakness, skin sores, hypothyroidism and Menkes disease (31) .
Studies in oral cancer and pre-cancer
The cellular accumulation of zinc also inhibits mitochondrial terminal oxidation and respiration. In addition to these metabolic effects, zinc accumulation exhibits anti-proliferative effects via its induction of mitochondrial apoptogenesis. Zinc accumulation also inhibits the invasive activities in malignant prostate cells. The anti-proliferative effects and the effects on invasion and migration occur through zinc activation of specific intracellular signalling pathways. Consequently, these effects impose anti-tumour actions by zinc (32, 33) . There is now compelling clinical and experimental evidence that zinc is an important factor in prostate cancer and also in other types of cancer. In relation to essential tumour cell activities, the effects of zinc can be categorized as intermediary metabolism and bioenergetic effects, motility and invasive effects, growth and proliferation effects. The actions of zinc on all three activities impose anti-tumour effects in malignant prostate cells and other tumour cells (34−36) .
The metabolic decrease in zinc and citrate occurs early in the development of malignancy. Therefore, one must conclude that the metabolic and bioenergetic effects of zinc are incompatible with the ability of the neoplastic cell to conduct its potential malignant activities. To alleviate this imposition, ZIP1 expression is silenced and zinc accumulation is prevented so as to provide the metabolic and bioenergetic requirements of the malignant process. The recent observation that zinc accumulation and ZIP1 protein expression are lower in the RWPE2 tumorigenic prostate cell line compared to the non-tumorigenic RWPE1 cell line supports the role of zinc and ZIP1 as tumour suppressors (37) . Zinc insufficiency has been associated with the potentiation for development of many tumours and conversely, zinc treatment inhibits development of the tumours. Fong et al reported that zinc deficiency promotes lingual and oesophageal tumorigenesis (38, 39) . Abnet et al determined that high human tissue zinc concentration was strongly associated with a reduced risk of developing oesophageal squamous cell carcinoma (40) . In head and neck cancers, systemic zinc deficiency was associated with increased tumour size and stage of the cancer (41) . Recent studies suggest that zinc stimulates the activity of kinases in specific signalling pathways.
Upper aero-digestive tract (UADT) cancer, including oesophageal and tongue tumours, is an important cause of morbidity and mortality worldwide (42) . The incidence of UADT cancer is increasing worldwide, including in young adults and those without the known risk factors of tobacco and alcohol use (43) . The survival with oral cancer, the major site being the tongue, is poor, with a five-year survival rate of only 10% (43) . Patients with oral cancer have a high mortality rate, because of field cancerization effects that result in second primary tumours, particularly in the oesophagus (44) . In addition, patients with oral cancer are frequently zinc deficient (45, 46) . Abnet et al established a direct connection between zinc deficiency and human oesophageal squamous cell carcinoma by using X-ray fluorescence spectroscopy to measure zinc, copper, iron, nickel and sulphur in oesophageal biopsy samples obtained from residents in a high ESCC incidence area in China (39, 47, 48) . Zinc replenishment rapidly reverses cell proliferation, stimulates apoptosis, corrects abnormal gene expression in oesophageal epithelium and inhibits tumorigenesis (37, 49, 50) .
A case-control study of oral cancer was conducted in western Washington state between 1983 and 1987. Cases were identified through a population-based registry, and controls were selected by telephone using random digit dialling. Subjects participated in a personal interview, completed a food-frequency questionnaire and submitted clippings from the nails of each great toe for the determination of selenium and zinc concentrations. The odds ratio [OR] for low selenium levels in nail tissue (lowest 25% of the distribution compared to the upper 75%) was 1.4 (95% confidence interval [CI] 1.0, 2.2). Likewise, the odds ratio for low zinc levels in nails was 1.6 (95% CI 1.0, 2.3) but for low dietary zinc, it was 1.0 (95% CI 0.7, 1.7). Men with oral cancer had lower nail selenium levels than did the controls (OR = 1.9), but women with oral cancer did not (OR = 0.6). Individuals 20 to 39 years of age with oral cancer, in particular, were more likely to have lower selenium levels in nail tissue than controls (OR = 16.4). There was a significant interaction between selenium and ascorbic acid levels which could not be explained by cigarette use. Subjects at greatest risk had low levels of both nutrients. However, since the elements were deposited in the nail matrix close to the date of diagnosis, the differences in the element concentrations between cases and controls may have been a result of the disease (51).
Serum levels of copper and zinc were analysed in 50 patients with oral cancer, 50 patients with oral leukoplakia and 50 patients with oral submucous fibrosis and the values were compared with those of 50 normal healthy adult controls. There was a significant reduction in the serum copper and zinc levels in both oral submucous fibrosis and oral cancer. The copper/zinc ratio was found to be elevated in oral submucous fibrosis and depressed in oral cancer. The ratio may serve as a good indicator for the early detection of oral cancer (52) .
Neoplastic diseases and infectious diseases have been reported to lead to changes in zinc metabolism as evidenced by alteration in plasma zinc (53) . The presence of these conditions that alter plasma zinc content may lead to accumulative zinc depletion in tissues. It has been observed that deficiencies of zinc in patients with inflammatory and infectious diseases have been attributed to loss of zinc from catabolic tissue and increased urinary excretion of zinc subsequent to its mobilization from interleukins (54) . Patients with cancer can excrete as much as three times more zinc than normal patients in their urine. Increased urinary zinc excretion in cancer patients may be linked to immune activation and renal tubular cell dysfunction and skeletal muscle catabolism (55) .
In malignancies, the normal zinc-accumulating, citrate-producing epithelial cells are metabolically transformed to citrate-oxidizing cells that lose the ability to accumulate zinc. A genetic alteration in the expression of ZIP1 zinc transporter is associated with this metabolic transformation. These metabolic or genetic relationships have important consequences on citrate related metabolism, bioenergetics, cell proliferation and invasive capabilities of the malignant cells which result in tumour suppressive characteristics. Zinc is critical to these relationships (56) . This pattern of change in zinc concentration (ie low plasma zinc and tissue zinc in combination with high urine zinc) is typical of patients with zinc deficiency due to diseases and suggests that a chronic zinc deficiency status may be present in some of these patients as the disease progresses (57) .
In a recent Indian study on micronutrient levels in oral cancer and pre-cancer conditions, the following observations were made: serum levels of copper showed gradual increase from pre-cancer to the cancer group as compared to healthy controls which was statistically significant. In oral leukoplakia, significant decrease in selenium level was reported (58) . Also, oral cancer showed reduced levels of selenium. In oral leukoplakia, significant decrease in selenium level was reported. Krishnaswamy et al reported decreased selenium levels in both oral and oropharyngeal cancer as compared to matched controls (59) .
Some researchers reported an inverse association between pre-diagnostic serum selenium concentrations and the risk of ESCC and gastric cardia cancer (60) . Recently, several prospective cohort studies and randomized intervention trials have reported an association between serum selenium concentrations and human chronic disease (61) . These studies suggest that selenium, an essential trace element for humans and a normal constituent of the diet, is anticarcinogenic (62−65) .
Although selenium supplementation showed no protective effect against skin cancer, it was associated with a statistically significant decrease in several secondary endpoints: total cancer mortality (52%), total cancer incidence (39%) and incidences of lung (44%), colorectal (61%) and prostate (65%) cancers (66, 67) .
CONCLUSION
Oral cancer is seen to arise from pre-existing leukoplakia and oral submucous fibrosis lesions. Increased incidence of oral cancer is seen in the presence of habits such as tobacco and alcohol consumption. A relative increase in oral cancer is seen in regions with marked nutritional deficiencies coupled with the use of carcinogenic products. Free radicals present in these products cause structural damage to DNA leading to carcinogenesis. Recent evidence suggests that a decrease in serum selenium and zinc levels and an increase in serum copper levels are seen in patients with carcinoma. This suggests that there is a relationship between micronutrients and the development of cancer. Trace elements such as zinc and selenium perform enzymatic and structural roles along with vitamin C, vitamin E and metals like copper to prevent DNA damage. Decrease in serum selenium and zinc levels in oral carcinoma patients can be attributed to their role as powerful antioxidants. Zinc and selenium supplements given to patients with head and neck cancer are seen to decrease the progression of cancer. Prevention and treatment of head and neck cancer may be possible with better understanding of the role of antioxidants and micronutrients in the development of the disease. Further research is necessary to confirm the role of micronutrients in the treatment of cancer.
